Market Cap

Clinuvel Pharmaceuticals Limited Market Capitalization:

A$851.7 Million

AUD as of July 1, 2024

US$567.2 Million

business Clinuvel Pharmaceuticals Limited Company Profile

Clinuvel Pharmaceuticals Limited Main Stock Listing

ASX: CUV

Market Capitalization History of Clinuvel Pharmaceuticals Limited

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Clinuvel Pharmaceuticals Limited market cap

Date Market Cap YoY Change
Jan. 1, 2024 A$804.5 M -33.81%
Jan. 1, 2023 A$1.22 B 11.99%
Jan. 1, 2022 A$1.09 B 2.72%
Jan. 31, 2021 A$1.06 B 3.27%
Jan. 1, 2021 A$1.02 B 22.12%
Jan. 31, 2020 A$837.8 M -35.85%
Jan. 1, 2020 A$1.31 B 3.63%
Jan. 31, 2019 A$1.26 B 25.20%
Jan. 1, 2019 A$1.01 B 144.56%
Jan. 31, 2018 A$411.6 M -1.91%
Jan. 1, 2018 A$419.6 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Clinuvel Pharmaceuticals Limited Categories

Australia languages Healthcare languages Biotechnology
Australia Healthcare Australia Biotechnology

Stocks & Indices

Clinuvel Pharmaceuticals Limited has the following listings and related stock indices.


Stock: ASX: CUV

Stock: FSX: UR9

Stock: Munich: UR9

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.